117 related articles for article (PubMed ID: 9017585)
21. Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer.
Kobayashi M; Matsui K; Hirashima T; Nitta T; Sasada S; Tada T; Minakuchi K; Furukawa M; Ogata Y; Kawase I
Int J Clin Oncol; 2006 Aug; 11(4):314-9. PubMed ID: 16937306
[TBL] [Abstract][Full Text] [Related]
22. Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer.
Berthaud P; Le Chevalier T; Ruffie P; Baldeyrou P; Arriagada R; Besson F; Tursz T
Eur J Cancer; 1992; 28A(11):1863-5. PubMed ID: 1327022
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancer.
Han JY; Kim KW; Kim JA; Kang JH; Jin JY; Hong YS; Park SY; Song JS; Park JW; Kim HK; Lee KS; Choi BG
Jpn J Clin Oncol; 2000 Oct; 30(10):435-9. PubMed ID: 11185889
[TBL] [Abstract][Full Text] [Related]
24. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
26. Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination.
Lokich J; Anderson N; Coco F
Cancer Invest; 2003; 21(6):830-6. PubMed ID: 14735686
[TBL] [Abstract][Full Text] [Related]
27. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
28. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer.
Campagnoli E; Garassino I; Santoro A; De Vincenzo F; Zucali PA; Ceresoli GL; Lutman FR; Alloisio M; Soto Parra HJ; Cavina R
Invest New Drugs; 2007 Dec; 25(6):559-64. PubMed ID: 17576521
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experience.
Goedhals L; Vorobiof DA; Bezwoda W; Van Merwe A; Jordaan JP; Barnardt P; Smith BL
Curr Med Res Opin; 1999; 15(3):185-92. PubMed ID: 10621925
[TBL] [Abstract][Full Text] [Related]
31. A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.
Chen YM; Perng RP; Shih JF; Whang-Peng J
Lung Cancer; 2008 Aug; 61(2):214-9. PubMed ID: 18243407
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.
Cobo-Dols M; Gil-Calle S; Villar-Chamorro E; Alés-Díaz I; Carabantes-Ocón F; Alcalde-García J; Gutiérrez-Calderón V; Montesa-Pino A; Bretón-García JJ; Benavides-Orgaz M
Clin Transl Oncol; 2006 Jul; 8(7):519-24. PubMed ID: 16870542
[TBL] [Abstract][Full Text] [Related]
33. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
[TBL] [Abstract][Full Text] [Related]
34. Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer.
Jassem J; Kosmidis P; Ramlau R; Zarogoulidis K; Novakova L; Breton J; Etienne PL; Seebacher C; Grivaux M; Ojala A; Aubert D; Lefresne F
Ann Oncol; 2003 Nov; 14(11):1634-9. PubMed ID: 14581271
[TBL] [Abstract][Full Text] [Related]
35. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
36. Tirapazamine with cisplatin and vinorelbine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Gatineau M; Rixe O; Chevalier TL
Clin Lung Cancer; 2005 Mar; 6(5):293-8. PubMed ID: 15845180
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
Langer CJ; Somer R; Litwin S; Feigenberg S; Movsas B; Maiale C; Sherman E; Millenson M; Nicoloau N; Huang C; Treat J
J Thorac Oncol; 2007 Mar; 2(3):203-9. PubMed ID: 17410043
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).
Pereira JR; Martins SJ; Nikaedo SM; Ikari FK
BMC Cancer; 2004 Sep; 4():69. PubMed ID: 15456520
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
Rey F; Astoul P; Marqueste L; Petite JM; Boutin C; Viallat JR
Am J Clin Oncol; 1998 Oct; 21(5):518-22. PubMed ID: 9781613
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
